Tuberculosis and COVID-19, the New Cursed Duet: What Differs Between Brazil and Europe?

Overview

Journal J Bras Pneumol

Specialty Pulmonary Medicine

Date 2021 May 5

PMID 33950095

Citations 11

Authors

Denise Rossato Silva

Fernanda Carvalho de Queiroz Mello

Lia DAmbrosio

Rosella Centis

Margareth Pretti Dalcolmo

Giovanni Battista Migliori

Affiliations

Soon will be listed here.

Abstract

On April 1st, 2020, COVID-19 surpassed tuberculosis regarding the number of deaths per day worldwide. The combination of tuberculosis and COVID-19 has great potential for morbidity and mortality. In addition, the COVID-19 pandemic has had a significant impact on the diagnosis and treatment of tuberculosis. In this review article, we address concurrent tuberculosis and COVID-19, with particular regard to the differences between Brazil and Europe. In addition, we discuss priorities in clinical care, public health, and research.

Citing Articles

Time series of cases and treatment outcomes from tuberculosis in Sergipe, 2012-2021.

Batista J, Santos V, Jesus C, Lima S Rev Bras Epidemiol. 2023; 26:e230041.

PMID: 37729348 PMC: 10511026. DOI: 10.1590/1980-549720230041.

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study.

Nalunjogi J, Mucching-Toscano S, Sibomana J, Centis R, DAmbrosio L, Alffenaar J Int J Infect Dis. 2023; 130 Suppl 1:S25-S29.

PMID: 36893943 PMC: 9991328. DOI: 10.1016/j.ijid.2023.02.025.

Clinical forms and diagnosis of tuberculosis in children and adolescents during the COVID-19 pandemic.

Pinheiro M, Aurilio R, Parente A, SantAnna M, Frota A, Hofer C J Bras Pneumol. 2022; 48(6):e20220240.

PMID: 36449819 PMC: 9747159. DOI: 10.36416/1806-3756/e20220240.

Impact of COVID-19 on Tuberculosis Indicators in Brazil: A Time Series and Spatial Analysis Study.

Berra T, Ramos A, Alves Y, Tavares R, Tartaro A, Nascimento M Trop Med Infect Dis. 2022; 7(9).

PMID: 36136658 PMC: 9500936. DOI: 10.3390/tropicalmed7090247.

Development of New Antimycobacterial Sulfonyl Hydrazones and 4-Methyl-1,2,3-thiadiazole-Based Hydrazone Derivatives.

Angelova V, Pencheva T, Vassilev N, K-Yovkova E, Mihaylova R, Petrov B Antibiotics (Basel). 2022; 11(5).

PMID: 35625207 PMC: 9137698. DOI: 10.3390/antibiotics11050562.

References

Alagna R, Besozzi G, Codecasa L, Gori A, Migliori G, Raviglione M . Celebrating World Tuberculosis Day at the time of COVID-19. Eur Respir J. 2020; 55(4). PMC: 7113797. DOI: 10.1183/13993003.00650-2020. View

Esposito S, Principi N, Leung C, Migliori G . Universal use of face masks for success against COVID-19: evidence and implications for prevention policies. Eur Respir J. 2020; 55(6). PMC: 7191114. DOI: 10.1183/13993003.01260-2020. View

Wilson F, Miller T, Stimpson J . COVID-19 and TB control in immigrant communities. Int J Tuberc Lung Dis. 2020; 24(9):975-977. DOI: 10.5588/ijtld.20.0456. View

Visca D, Zampogna E, Sotgiu G, Centis R, Saderi L, DAmbrosio L . Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae. Eur Respir J. 2019; 53(3). DOI: 10.1183/13993003.02184-2018. View

Visca D, Centis R, DAmbrosio L, Munoz-Torrico M, Chakaya J, Tiberi S . The need for pulmonary rehabilitation following tuberculosis treatment. Int J Tuberc Lung Dis. 2020; 24(7):720-722. DOI: 10.5588/ijtld.20.0030. View

Tadolini M, Codecasa L, Garcia-Garcia J, Blanc F, Borisov S, Alffenaar J . Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020; 56(1). PMC: 7251245. DOI: 10.1183/13993003.01398-2020. View

Yadav S, Rawal G . The case of pulmonary tuberculosis with COVID-19 in an Indian male-a first of its type case ever reported from South Asia. Pan Afr Med J. 2020; 36:374. PMC: 7666697. DOI: 10.11604/pamj.2020.36.374.24260. View

Visca D, Ong C, Tiberi S, Centis R, DAmbrosio L, Chen B . Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology. 2021; 27(2):151-165. PMC: 7825946. DOI: 10.1016/j.pulmoe.2020.12.012. View

Dara M, Sotgiu G, Reichler M, Chiang C, Chee C, Migliori G . New diseases and old threats: lessons from tuberculosis for the COVID-19 response. Int J Tuberc Lung Dis. 2020; 24(5):544-545. DOI: 10.5588/ijtld.20.0151. View

10.

Motta I, Centis R, DAmbrosio L, Garcia-Garcia J, Goletti D, Gualano G . Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020; 26(4):233-240. PMC: 7221402. DOI: 10.1016/j.pulmoe.2020.05.002. View

11.

Meneguim A, Rebello L, Das M, Ravi S, Mathur T, Mankar S . Adapting TB services during the COVID-19 pandemic in Mumbai, India. Int J Tuberc Lung Dis. 2020; 24(10):1119-1121. DOI: 10.5588/ijtld.20.0537. View

12.

Migliori G, Visca D, Boom M, Tiberi S, Silva D, Centis R . Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. Pulmonology. 2021; 27(3):248-256. PMC: 7843149. DOI: 10.1016/j.pulmoe.2020.12.016. View

13.

Pinheiro D, Pessoa M, Lima C, Holanda J . Tuberculosis and coronavirus disease 2019 coinfection. Rev Soc Bras Med Trop. 2020; 53:e20200671. PMC: 7670739. DOI: 10.1590/0037-8682-0671-2020. View

14.

Torre A, Aliberti S, Castellotti P, Cirillo D, Grisolia A, Mangioni D . Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy. Respir Med. 2020; 175:106204. PMC: 7645275. DOI: 10.1016/j.rmed.2020.106204. View

15.

Moran A, Mphahlele M, Mvusi L, Dlamini C, Ahmedov S, Jassim AlMossawi H . Learning from tuberculosis: COVID-19 highlights the need for more robust infection control policy. J Glob Health. 2020; 10(2):020328. PMC: 7561217. DOI: 10.7189/jogh.10.020328. View

16.

Visca D, Tiberi S, Pontali E, Spanevello A, Migliori G . Tuberculosis in the time of COVID-19: quality of life and digital innovation. Eur Respir J. 2020; 56(2). PMC: 7278505. DOI: 10.1183/13993003.01998-2020. View

17.

Ong C, Migliori G, Raviglione M, Macgregor-Skinner G, Sotgiu G, Alffenaar J . Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of.... Eur Respir J. 2020; 56(4). PMC: 7527651. DOI: 10.1183/13993003.01727-2020. View

18.

Duarte R, Aguiar A, Pinto M, Furtado I, Tiberi S, Lonnroth K . Different disease, same challenges: Social determinants of tuberculosis and COVID-19. Pulmonology. 2021; 27(4):338-344. PMC: 7894090. DOI: 10.1016/j.pulmoe.2021.02.002. View

19.

Casco N, Jorge A, Palmero D, Alffenaar J, Fox G, Ezz W . TB and COVID-19 co-infection: rationale and aims of a global study. Int J Tuberc Lung Dis. 2021; 25(1):78-80. DOI: 10.5588/ijtld.20.0786. View

20.

de Souza C, Coutinho H, Costa M, Magalhaes M, Carmo R . Impact of COVID-19 on TB diagnosis in Northeastern Brazil. Int J Tuberc Lung Dis. 2020; 24(11):1220-1222. DOI: 10.5588/ijtld.20.0661. View